TMEM18-DT: A Potential Drug Target or Biomarker (G105373354)

Target Name: TMEM18-DT

NCBI ID: G105373354

TMEM18-DT

Other Name(s): TMEM18-DT variant X4 | TMEM18 divergent transcript | TMEM18 divergent transcript, transcript variant X4

TMEM18-DT: A Potential Drug Target or Biomarker

TMEM18-DT (TMEM18-DT variant X4) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the transmembrane protein family, which means that it spans the cell membrane and functions as a channel or receptor protein. TMEM18-DT has been shown to play a role in a variety of physiological processes in the body, including blood vessel formation, neural signaling, and kidney function.

Recent studies have suggested that TMEM18-DT may be a drug target or biomarker for a variety of diseases. One potential mechanism by which TMEM18-DT could be targeted by drugs is through its role in neural signaling. TMEM18-DT has been shown to play a role in the regulation of neurotransmitter release from neurons, which is critical for proper functioning of the nervous system.

Additionally, TMEM18-DT has been shown to be involved in the formation of blood vessels in the brain, which is important for delivering oxygen and nutrients to the brain. The loss of blood vessels in the brain is a risk factor for a variety of neurological disorders, including Alzheimer's disease and Parkinson's disease.

Another potential mechanism by which TMEM18-DT could be used as a drug target is its role in kidney function. TMEM18-DT has been shown to play a role in regulating the balance of water and solutes in the kidneys, which is critical for maintaining proper kidney function. The kidneys are responsible for removing waste products and excess fluid from the blood, and they work closely with the brain to regulate water and electrolyte levels in the body.

In conclusion, TMEM18-DT is a protein that has been shown to play a variety of important roles in various physiological processes in the body. Its potential as a drug target or biomarker makes it an attractive target for researchers and pharmaceutical companies looking for new treatments for a variety of diseases. Further research is needed to fully understand the role of TMEM18-DT in neural signaling, blood vessel formation, and kidney function, and to determine its potential as a drug target.

Protein Name: TMEM18 Divergent Transcript

The "TMEM18-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM18-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets